Catherine Laughlin

2.6k total citations · 1 hit paper
31 papers, 2.0k citations indexed

About

Catherine Laughlin is a scholar working on Genetics, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Catherine Laughlin has authored 31 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 11 papers in Infectious Diseases and 11 papers in Molecular Biology. Recurrent topics in Catherine Laughlin's work include Virus-based gene therapy research (13 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Mosquito-borne diseases and control (5 papers). Catherine Laughlin is often cited by papers focused on Virus-based gene therapy research (13 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Mosquito-borne diseases and control (5 papers). Catherine Laughlin collaborates with scholars based in United States, United Kingdom and Brazil. Catherine Laughlin's co-authors include Barrie J. Carter, Helen Coon, David M. Morens, Donald S. Burke, Colin R. Parrish, Linda J. Saif, Charles H. Calisher, Edward C. Holmes, Peter Daszak and Jon-Duri Tratschin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Annals of Neurology.

In The Last Decade

Catherine Laughlin

30 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cross-Species Virus Transmission and the Emergence of New Epidemic Diseases

2008 588 citations David M. Morens, Catherine Laughlin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Laughlin United States	19	987	729	683	450	328	31	2.0k
Katherine R. Spindler United States	26	1.3k 1.3×	1.3k 1.8×	755 1.1×	740 1.6×	263 0.8×	65	3.1k
Gholamreza Darai Germany	25	588 0.6×	553 0.8×	731 1.1×	1.1k 2.5×	179 0.5×	88	2.6k
M B Gardner United States	28	786 0.8×	753 1.0×	396 0.6×	739 1.6×	110 0.3×	59	2.4k
Paulo César Peregrino Ferreira Brazil	29	448 0.5×	784 1.1×	430 0.6×	977 2.2×	329 1.0×	78	2.5k
Verónica Martı́n Spain	24	518 0.5×	648 0.9×	660 1.0×	384 0.9×	134 0.4×	64	1.9k
Robert Vigne France	31	606 0.6×	814 1.1×	859 1.3×	1.0k 2.3×	143 0.4×	68	2.8k
G. Darai Germany	27	342 0.3×	353 0.5×	566 0.8×	867 1.9×	145 0.4×	84	2.0k
R. Walter Schlesinger United States	24	469 0.5×	523 0.7×	555 0.8×	463 1.0×	493 1.5×	58	1.6k
Jennifer Richardson France	25	315 0.3×	691 0.9×	494 0.7×	757 1.7×	455 1.4×	77	2.1k
Antonito T. Panganiban United States	31	690 0.7×	1.8k 2.4×	1.3k 1.9×	799 1.8×	392 1.2×	65	3.6k

Countries citing papers authored by Catherine Laughlin

Since Specialization

Citations

This map shows the geographic impact of Catherine Laughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Laughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Laughlin more than expected).

Fields of papers citing papers by Catherine Laughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Laughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Laughlin. The network helps show where Catherine Laughlin may publish in the future.

Co-authorship network of co-authors of Catherine Laughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Laughlin. A scholar is included among the top collaborators of Catherine Laughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Laughlin. Catherine Laughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomas, Stephen J., Liane Agulto, Kay M. Tomashek, et al.. (2018). Dengue illness index—A tool to characterize the subjective dengue illness experience. PLoS neglected tropical diseases. 12(10). e0006593–e0006593. 5 indexed citations

Jaenisch, Thomas, Liane Agulto, Kay M. Tomashek, et al.. (2018). Development of standard clinical endpoints for use in dengue interventional trials: introduction and methodology. BMC Medical Research Methodology. 18(1). 134–134. 5 indexed citations

Krause, Philip R., Stephanie R. Bialek, Suresh B. Boppana, et al.. (2013). Priorities for CMV vaccine development. Vaccine. 32(1). 4–10. 110 indexed citations

Laughlin, Catherine, et al.. (2012). Dengue Research Opportunities in the Americas. The Journal of Infectious Diseases. 206(7). 1121–1127. 60 indexed citations

Laughlin, Catherine. (2012). Pink slime. The New Scientist. 214(2863). 28–28.

Cassetti, M. Cristina, Anna P. Durbin, Eva Harris, et al.. (2010). Report of an NIAID workshop on dengue animal models. Vaccine. 28(26). 4229–4234. 59 indexed citations

Greenstone, Heather L., et al.. (2007). NIAID resources for developing new therapies for severe viral infections. Antiviral Research. 78(1). 51–59. 8 indexed citations

Grober, Matthew S., et al.. (1994). GnRH Cell Size and Number in a Teleost Fish with Two Male Reproductive Morphs: Sexual Maturation, Final Sexual Status and Body Size Allometry. Brain Behavior and Evolution. 43(2). 61–78. 64 indexed citations

Spring, Susan B., Catherine Laughlin, Ann M. Arvin, et al.. (1994). Workshop summary. Annals of Neurology. 35(S1). S2–S3. 28 indexed citations

10.

Whitley, Richard J., A Arvin, Charles G. Prober, et al.. (1992). A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. International Journal of Gynecology & Obstetrics. 37(1). 68–68. 10 indexed citations

11.

Laughon, Barbara E., H.S. Allaudeen, Jerrold M. Becker, et al.. (1991). Summary of the Workshop on Future Directions in Discovery and Development of Therapeutic Agents for Opportunistic Infections Associated with AIDS. The Journal of Infectious Diseases. 164(2). 244–251. 35 indexed citations

12.

Rothenberg, Mace L., Gregory A. Johnson, Catherine Laughlin, et al.. (1989). Oligodeoxynucleotides as Anti-Sense Inhibitors of Gene Expression: Therapeutic Implications. JNCI Journal of the National Cancer Institute. 81(20). 1539–1544. 47 indexed citations

13.

Paul, William E., Catherine Laughlin, & Margaret I. Johnston. (1989). Report of Nomenclature Discussion. Annals of the New York Academy of Sciences. 557(1). 579–580. 5 indexed citations

14.

Schreier, Alan A., et al.. (1988). Prospects for Human Papillomavirus Vaccines and Immunotherapies1. JNCI Journal of the National Cancer Institute. 80(12). 896–899. 4 indexed citations

15.

Laughlin, Catherine, Jon-Duri Tratschin, Helen Coon, & Barrie J. Carter. (1983). Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene. 23(1). 65–73. 236 indexed citations

16.

Myers, Maureen, et al.. (1980). Adenovirus helper function for growth of adeno-associated virus: effect of temperature-sensitive mutations in adenovirus early gene region 2. Journal of Virology. 35(1). 65–75. 57 indexed citations

17.

Alpert, Susan, et al.. (1979). Orogenital Contact and the Isolation of Neisseria gonorrhoeae, Mycoplasma hominis, and Ureaplasma urealyticum from the Pharynx. Sexually Transmitted Diseases. 6(2). 64–68. 32 indexed citations

18.

Carter, Barrie J., Catherine Laughlin, Luis M. de la Maza, & Maureen Myers. (1979). Adeno-associated virus autointerference. Virology. 92(2). 449–462. 100 indexed citations

19.

Laughlin, Catherine, et al.. (1979). Defective-interfering particles of the human parvovirus adeno-associated virus. Virology. 94(1). 162–174. 62 indexed citations

20.

Laughlin, Catherine & William A. Strohl. (1976). Factors regulating cellular DNA synthesis induced by adenovirus infection. Virology. 74(1). 30–43. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact